- Merger with Pura Vida Health seen as mutually beneficial for both players in the CBD health and wellness space
- EMOR’s Pura Vida business plan allows the company to achieve full vertical integration
- The company promises quality control of CBD product offerings, from seed to shelf
Emerald Organic Products Inc. (OTC: EMOR), a diversified cannabidiol (CBD)-focused health sciences company, recently announced the completion of a definitive plan to merge with Pura Vida Health LLC, a health and wellness company focused on using natural ingredients – including the increasingly desired CBD – to help customers achieve optimal health. This mutually beneficial merger is expected to allow Pura Vida to become a flagship brand for Emerald Organic Products and position the former for maximum market penetration, with the help of EMOR’s proven track record in product branding and sales.
“We believe in the all-star team we put together, we have proven experts in cannabis, hemp, CBD,” Pura Vida CEO and Executive Chairman Matt Dill stated in a news release (http://cnw.fm/vwu6Z). “I am talking all phases: planting, farming, extracting, the whole way, fully vertical.” Commenting on how his company will benefit from the alignment with Emerald Organic Products, he noted, “Add a group of professionals with a track record of successful branding of products, hundreds of millions in sales, [it’s] very exciting.”
Pura Vida is focused on bringing products to market that are engineered to help people live their healthiest lives. The company is committed to providing the highest quality products using natural ingredients and third-party testing (http://cnw.fm/Xq1fm). Coupling Pura Vida’s insistence on quality with EMOR’s marketing muscle is expected to lend the combined firm an advantageous position in the burgeoning industry.
Based out of New York, Emerald Organics Products plans to market its recently commercialized line of vitamins and supplements both across the nation and in certain foreign countries. Its Pura Vida business plan will allow it to achieve full vertical integration – ensuring absolute quality control, from seed to shelf. The process includes careful monitoring of hemp growth and CBD extraction and following the product through manufacturing and production at its facilities in Oregon and New York, respectively. By overseeing each stage, Emerald Organics Products will be one step closer to its goal of ‘leading the hemp revolution’ (http://cnw.fm/7J9xc).
Creating a symbiotic relationship between the two companies, the merger comes at an opportune time. According to Grand View Research, the global cannabidiol market was valued at $4.6 billion in 2018 and is forecast to experience an impressive CAGR of 22.2% through 2025 (http://cnw.fm/AFB3u). In the health and wellness industry, there is particularly high demand for products infused with CBD due to its healing properties, including its efficacy in treating anxiety, depression and stress; its mitigation of cancer symptoms; and other applications. As government legalization and approval continue to roll through North America, the potential for companies bringing CBD offerings to market is also anticipated to grow.
Emerald Organic Products Inc. is engaged in the development of vitamins and supplements with cannabidiol (CBD) health and wellness products. The hemp-based proprietary Pura Vida CBD products include CBD vitamins, chewable CBD gummies and gummy bears, vaporization CBD liquids, drinks, CBD tinctures, CBD cosmetics and others.
For more information, visit the company’s website at www.Emerald-Organic.com
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.